Opportunity Information: Apply for RFA HL 25 010
Apply for RFA HL 25 010
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Phased Multi-Site Clinical Trial: Testing Prevention of Cardiovascular Disease in Young Adults With High Lifetime Risk Using Surrogate Outcomes - Clinical Coordinating Center (Collaborative UG3/UH3 Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.837.
- This funding opportunity was created on 2024-07-10.
- Applicants must submit their applications by 2024-10-28. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2025.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Previous opportunity: National Tsunami Hazard Mitigation Program Grant Cycle 2025
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HL 25 010
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HL 25 010) also looked into and applied for these:
| Funding Opportunity |
|---|
| Tissue Chips in Space 2.0: Translational Multi-Organ Tissue Chip Systems for Drug Efficacy, Toxicity Testing, and Personalized Medicine in Human Health, Aging and Associated Diseases (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA TR 24 025 Funding Number: RFA TR 24 025 Funding Amount: $750,000 |
| Develop and Test HIV Prevention Interventions for Black and Hispanic Gay, Bisexual, and Other Men Who Have Sex with Men Who Use Substances Apply for RFA PS 25 113 Funding Number: RFA PS 25 113 Funding Amount: $475,000 |
| Increasing Access to HIV Confidential Voluntary Counseling and Testing (VCT) and Enhancing HIV/AIDS Communications, Prevention, and Care in the Kingdom of Lesotho under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 115505CONT16 Funding Number: CDC RFA GH11 115505CONT16 Funding Amount: Case Dependent |
| Access and Enhancing Quality of Integrated HIV Confidential, Voluntary Testing Apply for CDC RFA GH11 112805CONT16 Funding Number: CDC RFA GH11 112805CONT16 Funding Amount: Case Dependent |
| Increasing Access to HIV Counseling and Testing Services for High-Risk Populations, and Improving Linkage, Engagement and Retention in Care and Support Services in the Federal Democratic Republic of Ethiopia under the President’s Emergency Plan for Apply for CDC RFA GH15 152402CONT16 Funding Number: CDC RFA GH15 152402CONT16 Funding Amount: Case Dependent |
| Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed) Apply for RFA HL 26 019 Funding Number: RFA HL 26 019 Funding Amount: Case Dependent |
| Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required) Apply for PAR 25 183 Funding Number: PAR 25 183 Funding Amount: Case Dependent |
| Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required) Apply for PAR 25 184 Funding Number: PAR 25 184 Funding Amount: Case Dependent |
| Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required) Apply for PAR 25 285 Funding Number: PAR 25 285 Funding Amount: Case Dependent |
| NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional) Apply for PAR 25 445 Funding Number: PAR 25 445 Funding Amount: Case Dependent |
| Mucosal Immunology Studies Team (MIST) (U01 Clinical Trial Not Allowed) Apply for RFA AI 25 018 Funding Number: RFA AI 25 018 Funding Amount: $350,000 |
| Claude D. Pepper Older Americans Independence Centers (P30 Clinical Trial Optional) Apply for RFA AG 26 025 Funding Number: RFA AG 26 025 Funding Amount: $925,000 |
| Tuberculosis Research Units (P01 Clinical Trial Optional) Apply for RFA AI 25 027 Funding Number: RFA AI 25 027 Funding Amount: Case Dependent |
| Partnerships for Development of Vaccines to Prevent Mycobacterium tuberculosis Infection and/or Disease (R01 Clinical Trial Not Allowed) Apply for RFA AI 25 022 Funding Number: RFA AI 25 022 Funding Amount: $750,000 |
| Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed) Apply for RFA AI 25 010 Funding Number: RFA AI 25 010 Funding Amount: Case Dependent |
| Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed) Apply for RFA HL 26 012 Funding Number: RFA HL 26 012 Funding Amount: Case Dependent |
| Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial Not Allowed) Apply for PAR 25 441 Funding Number: PAR 25 441 Funding Amount: Case Dependent |
| Influenza Transmission Research Consortium (P01 Clinical Trial Optional) Apply for RFA AI 25 035 Funding Number: RFA AI 25 035 Funding Amount: Case Dependent |
| NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 Independent Clinical Trial Not Allowed) Apply for RFA AG 26 010 Funding Number: RFA AG 26 010 Funding Amount: $400,000 |
| Artificial Intelligence and Technology Collaboratory Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA AG 26 007 Funding Number: RFA AG 26 007 Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HL 25 010", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.